Monteplase

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameMonteplase
Drug Alias Namemonteplasa孟替普酶monteplasumCleactorE-6010 +[6] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsMyocardial InfarctionPulmonary Embolism
Global Approved IndicationsMyocardial InfarctionPulmonary Embolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1998/06/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEisai Co Ltd
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionPulmonary Embolism
Inactive IndicationsN/A

Other Information

ATC CodeB01AD
Related LinksWikipediaKEGG